Related Experiment Videos
[On-off fluctuations]
1Clinique Neurologique, Centre d'Investigation Clinique, INSERM U437, CHUNantes.
Revue Neurologique
|April 12, 2003
Summary
Dopamine treatment fluctuations in Parkinson's disease, affecting over 50% of patients after 5 years, stem from brain dopamine changes and complex neural circuitry issues. Understanding these mechanisms is key to effective management.
Area of Science:
- Neuroscience
- Neurology
- Pharmacology
Background:
- Motor fluctuations are a common complication of dopaminergic therapy in Parkinson's disease (PD).
- Over 50% of PD patients experience fluctuations after 5 years of treatment.
- Both disease progression and the dopaminergic treatment itself contribute to these fluctuations.
Purpose of the Study:
- To elucidate the underlying mechanisms of motor fluctuations in Parkinson's disease.
- To highlight the importance of understanding pharmacokinetic and postsynaptic factors.
- To emphasize the role of detailed clinical assessment in managing treatment efficacy.
Main Methods:
- Review of current understanding of dopaminergic treatment complications in PD.
- Analysis of pharmacokinetic alterations in brain dopamine.
- Examination of postsynaptic anomalies within basal ganglia circuitry.
Main Results:
- Pharmacokinetic alterations, specifically reduced dopamine storage capacity, are implicated in fluctuations.
- Complex postsynaptic abnormalities affecting basal ganglia circuitry also play a significant role.
- A detailed semiologic analysis is crucial for understanding fluctuation patterns.
Conclusions:
- Motor fluctuations in Parkinson's disease result from a combination of altered dopamine pharmacokinetics and postsynaptic changes.
- Precise chronological and clinical assessment of fluctuations is essential before therapeutic interventions.
- Further research into basal ganglia circuitry is needed to fully address treatment efficacy issues.